Clal Biotechnology Industries Ltd. (TASE: CBI) today announced that Sight Diagnostics, a portfolio company of Anatomy, Clal Biotechnology’s investment fund for medical devices, had raised $28 million.
Read more on Globes here.
Clal Biotechnology Industries Ltd. (TASE: CBI) today announced that Sight Diagnostics, a portfolio company of Anatomy, Clal Biotechnology’s investment fund for medical devices, had raised $28 million.
Read more on Globes here.
![[Taranis in The Argus-Press] Precision Ag Leader Taranis Hires New CEO to Lead Next Stage of Company Growth](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
![[Binah.ai in PRNewswire] Sapiens and Binah.ai partner to empower global life insurers to improve risk management with AI](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-link.svg)
